ID GLC-4/ADR AC CVCL_4997 SY GLC4-Adr; GLC4/ADR; GLC(4)/ADR; GLC4/ADR350x; GLC4-ADR150; GLC4-Adr1 DR BTO; BTO_0002386 DR ChEMBL-Cells; CHEMBL3833703 DR PubChem_Cell_line; CVCL_4997 DR Wikidata; Q54835913 RX PubMed=1657425; RX PubMed=3028613; RX PubMed=3040227; RX PubMed=7729950; RX PubMed=7809167; RX PubMed=8980384; RX PubMed=11309308; CC Doubling time: 26 hours (PubMed=3028613). CC Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line). CC Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. DI NCIt; C4917; Lung small cell carcinoma DI ORDO; Orphanet_70573; Small cell lung cancer OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0279 ! GLC-4 SX Male AG Age unspecified CA Cancer cell line DT Created: 04-04-12; Last updated: 19-12-24; Version: 18 CH CVCL_A5AZ ! GLC-4/ADRpr // RX PubMed=7809167; DOI=10.1073/pnas.91.26.13033; PMCID=PMC45575; RA Muller, Michael RA Meijer, Coby RA Zaman, Guido J.R. RA Borst, Piet RA Scheper, Riekeld J. RA Mulder, Nanno H. RA de Vries, Elisabeth Geertruida Emma RA Jansen, Peter L.M. RT "Overexpression of the gene encoding the multidrug RT resistance-associated protein results in increased ATP-dependent RT glutathione S-conjugate transport."; RL Proc. Natl. Acad. Sci. U.S.A. 91:13033-13037(1994). // RX PubMed=11309308; RA Maliepaard, Marc RA Scheffer, George L. RA Faneyte, Ian F. RA van Gastelen, Margot A. RA Pijnenborg, Adriana C.L.M. RA Schinkel, Alfred H. RA van de Vijver, Marc Joan RA Scheper, Riekeld J. RA Schellens, Jan H.M. RT "Subcellular localization and distribution of the breast cancer RT resistance protein transporter in normal human tissues."; RL Cancer Res. 61:3458-3464(2001). // RX PubMed=3040227; RA Meijer, Coby RA Mulder, Nanno H. RA Timmer-Bosscha, Hetty RA Zijlstra, Jan G. RA de Vries, Elisabeth Geertruida Emma RT "Role of free radicals in an adriamycin-resistant human small cell RT lung cancer cell line."; RL Cancer Res. 47:4613-4617(1987). // RX PubMed=3028613; RA Zijlstra, Jan G. RA de Vries, Elisabeth Geertruida Emma RA Mulder, Nanno H. RT "Multifactorial drug resistance in an adriamycin-resistant human small RT cell lung carcinoma cell line."; RL Cancer Res. 47:1780-1784(1987). // RX PubMed=8980384; DOI=10.1038/bjc.1996.647; PMCID=PMC2074800; RA Withoff, Sebo RA de Vries, Elisabeth Geertruida Emma RA Keith, William Nicol RA Nienhuis, Edith F. RA van der Graaf, Winette T.A. RA Uges, Donald Robert Alexander RA Mulder, Nanno H. RT "Differential expression of DNA topoisomerase II alpha and -beta in RT P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines RT of the human SCLC cell line GLC4."; RL Br. J. Cancer 74:1869-1876(1996). // RX PubMed=7729950; DOI=10.1002/ijc.2910610317; RA Versantvoort, Carolina H.M. RA Withoff, Sebo RA Broxterman, Henk J. RA Kuiper, Catharina M. RA Scheper, Riekeld J. RA Mulder, Nanno H. RA de Vries, Elisabeth Geertruida Emma RT "Resistance-associated factors in human small-cell lung-carcinoma GLC4 RT sub-lines with increasing adriamycin resistance."; RL Int. J. Cancer 61:375-380(1995). // RX PubMed=1657425; DOI=10.1007/BF00685823; RA de Jong, Steven RA Zijlstra, Jan G. RA Mulder, Nanno H. RA de Vries, Elisabeth Geertruida Emma RT "Lack of cross-resistance to fostriecin in a human small-cell lung RT carcinoma cell line showing topoisomerase II-related drug resistance."; RL Cancer Chemother. Pharmacol. 28:461-464(1991). //